Exmar (Belgium)

Clinical Judgment Versus Biomarker Prostate Cancer Gene 3: Which Is Best When Determining the Need for Repeat Prostate Biopsy?

Bertrand Tombal, Gerald L. Andriole, Alexandre de la Taille et al. · Urology · 2013 · 31 citations · Full text

Risk factors for disease progression in patients with lower urinary tract symptoms/benign prostatic hyperplasia (LUTS/BPH): a systematic analysis of expert opinion

Franklin C. Lowe, J.E. Batista, R. Berges et al. · Prostate Cancer and Prostatic Diseases · 2005 · 29 citations

Urology, Disease Progression, Expert Opinion +7

Integrating risk profiles for disease progression in the treatment choice for patients with lower urinary tract symptoms/benign prostatic hyperplasia: a combined analysis of external evidence and clinical expertise

Mark Speakman, J.E. Batista, R. Berges et al. · Prostate Cancer and Prostatic Diseases · 2005 · 13 citations

Urology, Disease Progression, Health Policy +9

Relationship Between Patient-Reported Outcomes and Clinical Outcomes in Patients With Morquio A Syndrome

Christina Lampe, Mohit Jain, Andrew Olaye et al. · Journal of Inborn Errors of Metabolism and Screening · 2015 · 11 citations · Full text